Showing results (161-170 of 280) with videos related to

Sort By:
Pageof 28
Clinical Genitourinary Cancer|May 15, 2018
Comprehensive Genomic Profiling of Metastatic Tumors in a Phase 2 Biomarker Study of Everolimus in Advanced Renal Cell CarcinomaXin Gao, Opeyemi Jegede, Connor Gray, et al.
Prostate Cancer and Prostatic Diseases|April 2, 2024
Emerging racial disparities among Medicare beneficiaries and Veterans with metastatic castration-sensitive prostate cancerDaniel J George, Neeraj Agarwal, Krishnan Ramaswamy, et al.
Prostate Cancer and Prostatic Diseases|February 12, 2024
Prognostic and predictive analyses of circulating plasma biomarkers in men with metastatic castration resistant prostate cancer treated with docetaxel/prednisone with or without bevacizumabAndrew B Nixon, Yingmiao Liu, Qian Yang, et al.
The Journal of Urology|September 18, 2009
Men older than 70 years have higher risk prostate cancer and poorer survival in the early and late prostate specific antigen erasLeon Sun, Arthur A Caire, Cary N Robertson, et al.
JCI Insight|January 8, 2025
Circulating immune biomarkers correlating with response in patients with metastatic renal cell carcinoma on immunotherapyJoyce Hwang, Eda Holl, Yuan Wu, et al.
The Patient|August 11, 2023
Discrete-Choice Experiment to Understand the Preferences of Patients with Hormone-Sensitive Prostate Cancer in the USA, Canada, and the UKJuan Marcos Gonzalez, Arijit Ganguli, Alicia K Morgans, et al.
International Journal of Radiation Oncology, Biology, Physics|December 1, 2020
Combination of Radiation Therapy and Short-Term Androgen Blockade With Abiraterone Acetate Plus Prednisone for Men With High- and Intermediate-Risk Localized Prostate CancerBridget F Koontz, Karen E Hoffman, Susan Halabi, et al.
Urology|October 10, 2009
Public survey and survival data do not support recommendations to discontinue prostate-specific antigen screening in men at age 75Arthur A Caire, Leon Sun, Cary N Robertson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2023
PSMA-positive Circulating Tumor Cell Detection and Outcomes with Abiraterone or Enzalutamide Treatment in Men with Metastatic Castrate-resistant Prostate CancerSantosh Gupta, Susan Halabi, Qian Yang, et al.
Prostate Cancer and Prostatic Diseases|April 1, 2026
Cytoplasmic versus nuclear localization of androgen receptor splice variant 7 as a predictor of benefit from androgen receptor pathway inhibitors in metastatic castration-resistant prostate cancer (PROPHECY trial)Santosh Gupta, Siyuan Guo, Susan Halabi, et al.
Pageof 28